Active Biotech, Ipsen to jointly develop cancer drug
TASQ binds to a molecule called S100A9 which is expressed in the white blood cells involved in the regulation of immune responses. As per the terms of the
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.